Parikh, Purvish

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

Thatcher, N., Chang, A., Parikh, P., Rodrigues Pereira, J., Ciuleanu, T., von Pawel, J., Thongprasert, S., Tan, E. H., Pemberton, K., Archer, V., et al. (2005) · The Lancet

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 2,079

Lung cancer immunotherapy: progress, pitfalls, and promises

Lahiri, A., Maji, A., Potdar, P. D., Singh, N., Parikh, P., Bisht, B., Mukherjee, A., & Paul, M. K. (2023) · Molecular Cancer

Cancer Immunotherapy and BiomarkersLung Cancer Research Studies

Cited by 1,102

Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer

Hirsch, F. R., Varella-Garcia, M., Bunn, P. A., Franklin, W. A., Dziadziuszko, R., Thatcher, N., Chang, A., Parikh, P., Pereira, J. R., Ciuleanu, T., et al. (2006) · Journal of Clinical Oncology

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research

Cited by 703

Challenges in Cervical Cancer Prevention: Real-World Scenario in India

Kaur, S., Sharma, L. M., Mishra, V., Goyal, M. G. B., Swasti, S., Talele, A., & Parikh, P. M. (2023) · South Asian Journal of Cancer

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 35

Judge Juan Manuel Padilla Garcia, ChatGPT, and a controversial medicolegal milestone

Parikh, P. M., Shah, D. M., & Parikh, K. P. (2023) · Indian Journal of Medical Sciences

Artificial Intelligence in LawArtificial Intelligence in Healthcare and Education

Cited by 24